| The therapeutic field | Project name | Dosage form/specification | Category | Indications | Remark |
|---|---|---|---|---|---|
| Anti-infective medication | Isaconazole sulfate | Injection (powder injection)/200 mg, 372 mg Capsule/100mg |
Category 3 chemical drugs |
Invasive fungal infection |
Pilot study |
| Lettermowe | Tablets/240mg, 480mg Injection/12ml: 240mg, 24ml: 480mg |
Category 4 chemical drugs |
Prevention of cytomegalovirus infection |
Pilot study |
|
| Putomani | Tablets/200 mg | Category 4 chemical drugs |
It is indicated for the treatment of adult patients with extensively drug-resistant (XDR), treatment-intolerant, or refractory multidrug-resistant (MDR) pulmonary tuberculosis (TB) as part of a combination regimen of bedaquiline and linezolid |
Pilot study |
|
| Mabaloshawe | Tablets/20 mg | Category 3 chemical drugs |
Has antiviral drug and is superior to oseltamivir. |
Complete the pilot test |
